Cardiac Membrane Biology Laboratory
The Cardiac Membrane Biology Laboratory aims to improve the lives of people suffering cardiac related health issues.
Our research focuses on one of the body’s most crucial molecules – a molecule which is vital for the contraction of heart cells and therefore the pumping of the heart. As we develop a better understanding of this molecule through laboratory-based experiments, we explore treatments for heart failure, irregular heartbeat and heart damage following cancer treatment.
Our laboratory-based research has led to the discovery of a new potential treatment for heart failure. We are about to begin a clinical trial of this approach with our collaborators based in Denmark.
Prof Helge Rasmussen.
Chair of Cardiology
Medicine, Northern Clinical School
Dr Elisha Hamilton, PhD
Laboratory Manager
Medicine, Northern Clinical School
PREVENTION OF CARDIAC SIDE EFFECTS OF CANCER TREATMENT
This project will investigate a new drug combination therapy that has potential benefits in cancer treatment induced heart failure by targeting the sodium/potassium pump function.
A NEW DRUG COMBINATION THERAPY FOR HEART FAILURE
This project will investigate a drug combination therapy that has potential benefits in heart failure treatment by targeting the sodium/potassium pump function.
Cardiac Membrane Biology Laboratory related information
Some recent media:
Events, News and Seminars
Common medication may lower risk of “heartbreak”
Posted on: 14 February, 2020
RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common med..... Read more
Category: Research Excellence
Research spotlight on specialist NICU team
Posted on: 22 January, 2020
Celebrity couple Hayden James and Jennifer Luby shared their emotional journey following the premat..... Read more
Category: Research Excellence
